Price Packages
Service Features
  • 275 words per page
  • Font: 12 point Courier New
  • Double line spacing
  • Free unlimited paper revisions
  • Free bibliography
  • Any citation style
  • No delivery charges
  • SMS alert on paper done
  • No plagiarism
  • Direct paper download
  • Original and creative work
  • Researched any subject
  • 24/7 customer support

It is sometimes difficult to be inspired when trying to write a persuasive essay, book report or thoughtful research paper. Often of times, it is hard to find words that best describe your ideas. VIPessays now provides a database of over 150,000 quotations and proverbs from the famous inventors, philosophers, sportsmen, artists, celebrities, business people, and authors that are aimed to enrich and strengthen your essay, term paper, book report, thesis or research paper.

Try our free search of constantly updated quotations and proverbs database.

QuotationsAuthorsTopicsKeywords

Search over 150,000 Quotations & Proverbs
Browse Authors: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
(Click a letter to view the authors)
Letter "C" » Chris Schott Quotes
«The company is not without controversy.»
Author: Chris Schott
«A lack of mergers has allowed them to stay focused on strategy, Their alliances have been a success.»
Author: Chris Schott
«We view this as a critical event in the Pfizer story and a potential positive catalyst for the stock.»
Author: Chris Schott
«It is our top pick. I like the lack of patent expirations...They have a portfolio of new products.»
Author: Chris Schott
«It is our top pick. I like the lack of patent expirations... They have a portfolio of new products.»
Author: Chris Schott
«We view this announcement, following Pfizer's 26% dividend increase in December 2005, as another sign that Pfizer is addressing shareholder concerns and as another step in the right direction for the company.»
Author: Chris Schott
«Trading at 12 times 2005 earnings, shares are reflecting a seemingly bearish view of Pfizer's growth prospects, in our opinion. With these low expectations built into the shares, we are encouraged that Pfizer's $4 billion cost restructuring will stabilize near-term earnings.»
Author: Chris Schott
«I think Hank's credibility has been hurt but I think he has admitted that. I think he needs to be upfront about how they are handling all the variables facing the business.»
Author: Chris Schott
Research our database of over 800,000 top-quality pre-written papers plus 15,000 biographies for only $9.95/month.
Instant Account Activation. Register Now.